Interviews

Interviews

Experts discuss practice-changing issues

Big Questions, Tough Answers

On October 17, 2017, Norman “Ned” Sharpless, MD, was sworn in as the 15th director of the National Cancer Institute (NCI), succeeding Harold E....

Setting a Course for 2020: The Search for the Next Blood Editor-in-Chief

On January 1, 2020, a new Editor-in-Chief will take the helm of Blood, the flagship journal of the American Society of Hematology (ASH). The...

Fighting for Hematology: ASH Bridge Grants and Grassroots Advocacy

After years of across-the-board funding cuts and steady budget declines, the National Institutes of Health (NIH) received a $2 billion increase in funding with...

A Cure for Congress?

An Interview With Jason Westin, MD As a hematologist and researcher, Jason Westin, MD, has dedicated his career to expanding and advancing treatment options for patients with...

Harnessing the Power of Collaboration

ASH Clinical News spoke with Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s (FDA) Oncology Center of Excellence (OCE), about the...

Long-Term Impact of the ASH Scholar Award Program

The American Society of Hematology’s (ASH) longest-running award program, the ASH Scholar Award, celebrates more than 30 years of financially supporting fellows and junior...

Revisiting Maintenance of Certification: Updates from ASH and ABIM Interview with Marc S....

In 2015, the American Board of Internal Medicine (ABIM) issued a statement in response to numerous criticisms from diplomates and specialty societies, including the...
Robert Negrin

If You Build It, They Will Come: Robert Negrin Shares His Vision for Blood...

When Robert Negrin, MD, was growing up in Silver Spring, Maryland, if someone had told his parents that their son would one day become...

Bridging the Gap: How ASH Bridge Grant Recipients are Advancing Research

Biomedical researchers are operating in a tepid – lukewarm, at best – funding environment. The National Institutes of Health (NIH), a major source of...

Grassroots Lobbying Efforts Lead to a Win for SCD Patients in Tennessee: An Interview...

Sickle cell disease (SCD) is the most common, inherited red blood cell disorder in the United States – affecting 70,000 to 100,000 Americans. Although...
Advertisement

Current Issue

September 2018, Volume 4, Issue 11

View issue flipbook September 2018 Volume 4, Issue 11This issue features a look at research misconduct, a debate about whether chronic lymphocytic leukemia is curable, and...